Elevated ratio of MMP2/MMP9 activity is associated with poor response to chemotherapy in osteosarcoma

Improved Survival in Osteosarcoma Patients with Atypical Low Vascularization

(2014) Pierre Kunz et al.   ANNALS OF SURGICAL ONCOLOGY

Matrix metalloproteinase 9 (MMP-9) in osteosarcoma: Review and meta-analysis

(2014) Jing Wang et al.   CLINICA CHIMICA ACTA

The prognostic role of matrix metalloproteinase 2 in gastric cancer: a systematic review with meta-analysis

(2014) Weisong Shen et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

A systematic review of matrix metalloproteinase 9 as a biomarker of survival in patients with osteosarcoma

(2014) Hui Li et al.   TUMOR BIOLOGY

Osteosarcoma treatment – Where do we stand? A state of the art review

(2013) Anja Luetke et al.   CANCER TREATMENT REVIEWS

Matrix Metalloproteinases 2, 7, 9 and Tissue Inhibitor of Matrix Metalloproteinase-1 in the Sera of Patients with Bone Tumors

(2010) N. E. Kushlinsky et al.   BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE

Expression of matrix metalloproteinases-2, -8, -13, -26, and tissue inhibitors of metalloproteinase-1 in human osteosarcoma

(2010) Jarkko T. Korpi et al.   SURGICAL ONCOLOGY-OXFORD